Phage-specific antibodies: are they a hurdle for the success of phage therapy?
2024
Phage-Specific Antibodies and Their Impact on Phage Therapy
publication
Evidence: moderate
Author Information
Author(s): Santini Joanne M, Washizaki Ayaka, Sakiyama Arata, Ando Hiroki
Primary Institution: Gifu University
Hypothesis
Do phage-specific antibodies influence the outcomes of phage therapy?
Conclusion
Phage-specific antibodies can lead to rapid clearance of phages from the body, potentially affecting the efficacy of phage therapy.
Supporting Evidence
- Phage-specific antibodies can promote phage uptake by macrophages.
- Neutralizing antibodies can diminish the antibacterial activity of phages.
- Clinical trials show inconsistent results regarding the influence of phage-specific antibodies on treatment outcomes.
Takeaway
When we use phages to fight bacteria, our body can make antibodies against them, which might make the treatment less effective.
Methodology
This review summarizes various studies on phage-specific antibodies and their effects on phage therapy outcomes.
Limitations
The relationship between phage-specific antibodies and clinical outcomes remains unclear and controversial.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website